Subramony Subramonia-Iyer

  • Citations Per Year
Learn More
David Oaks I would like to thank PLoS Medicine for publishing Lacasse and Leo’s important and methodical Essay that debunks the “chemical imbalance” advertisements for psychiatric drugs [1]. Why would the United States Food and Drug Administration (FDA) approve such ads? Our human rights group, MindFreedom International, has been asking that question for a(More)
271 Background: Mutated EGFR gene testing transformed the care of NSCLC. ASCO now recommends EGFR mutation testing for NSCLC (April 2011); however, no studies to assess quality of biopsy samples and adequacy for mutation testing have been done outside a trial setting. METHODS A retrospective chart review to identify patients diagnosed with NSCLC at a(More)
  • 1